Total raised
—
Stage
Pre-Funding
Founded
2008
Headcount
3
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
SyndromeX is a pharmaceutical company that develops drugs for metabolic syndrome and related diseases such as dyslipidemia, type-2 diabetes, obesity, hypertension, and atherosclerotic cardiovascular disease. In an effort to keep metabolic syndrome patients from having to take five to eight different drugs, SyndromeX aims to develop an all-in-one therapy for the disorder and its component diseases.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalscardiovascularobesityblood-pressurediabetesmetabolic-diseasecardiologychronic-patients